Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model

Dipeptidyl peptidase-4 inhibitors; Experimental diabetes; Retinal neurodegeneration

Bibliographic Details
Authors:	Bogdanov Baruj, Patricia, Ramos Abellan, Hugo, Valeri Sala, Marta, Deàs Just, Anna, Huerta Alonso, Jordi, Hernández Pascual, Cristina, Simó Canonge, Rafael
Format:	article
Status:	Published version
Publication Date:	2022
Country:	España
Institution:	Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:	Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:	oai:recercat.cat:11351/7887
Online Access:	https://hdl.handle.net/11351/7887 http://hdl.handle.net/11351/7887
Access Level:	Open access
Keyword:	Retinopatia diabètica - Tractament Posologia DISEASES::Eye Diseases::Retinal Diseases::Diabetic Retinopathy Other subheadings::Other subheadings::Other subheadings::/drug therapy ENFERMEDADES::oftalmopatías::enfermedades de la retina::retinopatía diabética Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

Description
Summary:	Dipeptidyl peptidase-4 inhibitors; Experimental diabetes; Retinal neurodegeneration